PeptideKey News

FDA Wegovy HD 7.2mg: 54-Day Priority Approval Signals [2026]

FDA approved semaglutide 7.2mg (Wegovy HD), tripling the dose ceiling. STEP UP trial: 21% weight loss, one-third hit 25%. Cleared in 54 days under CNPV program.

Loading full content...